Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avance Nerve Graft vs Autograft for Peripheral Nerve Reconstruction
NCT07657182Phase 4Recruiting
- Sponsor
- Axogen, Inc.
- Start
- Jun 2026
- Primary completion
- Dec 2030
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in peripheral nerve injury (PNI) (2 arms), sponsored by Axogen, Inc. Primary endpoints: Recovery of motor function at 24 months and Recovery of sensory function at 24 months. Started Jun 2026; status: recruiting.
02
Conditions
peripheral nerve injury (PNI)
Beyond the preview
Go deeper on NCT07657182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07657182.